A critical appraisal of a systematic review: Sokol J, Jacob SE, Bohn D: Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults: Cochrane Database Syst Rev 2003 (1): CD002787

Pediatric Critical Care Medicine

Volumn 6, Issue 3, 2005, Pages 340-343

  Thammasitboon, Satid ^a   Thammasitboon, Supat ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Evidence based medicine; Meta analysis

Indexed keywords

ANTIBIOTIC AGENT; NITRIC OXIDE; NITROGEN DIOXIDE; PLACEBO;

ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; HYPOXEMIA; INTENSIVE CARE; LENGTH OF STAY; META ANALYSIS; METHEMOGLOBINEMIA; MORTALITY; NEWBORN PERIOD; OXYGENATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 19444364991     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Richardson W, Wilson M, Nishikawa J, et al: The well-built clinical question: A key to evidence-based decisions. ACP J Club 1995; 123:A12-A13
2. Sokol J, Jacobs SE, Bohn D: Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2003; (1):CD002787
3. Sokol J, Jacobs SE, Bohn D: Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: A meta-analysis. Anesth Analg 2003; 97:989-998
4. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias: Dimension of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-412
5. Dellinger RP, Zimmerman JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 1998; 26:15-23
6. Michael JR, Barton G, Shaffle JR, et al: Inhaled nitric oxide versus conventional therapy: Effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157:1372-1380
7. Troncy E, Collet JP, Shapiro S, et al: Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study. Am J Respir Crit Care Med 1998; 157: 1483-1488
8. Dobyns EL, Cornfield DN, Anas NG, et al: Multicener randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999; 34: 406-412
9. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. Intensive Care Med 1999; 25:911-919
10. Angus DC, Clermont G, Watson RS, et al: Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics 2003; 112: 1351-1360
11. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336:597-604
12. Clark RH, Kueser TJ, Walker MW, et al: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342:469-474
13. LeLorier J, Gregoire G, Benhaddad, et al: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337:536-542